Quantcast
Last updated on April 17, 2014 at 14:44 EDT

Latest Colorectal cancer Stories

2013-10-08 12:28:02

Large, single-center study calls into question the use of sigmoidoscopy to screen for colon cancer in patients over age 60 WASHINGTON, Oct. 8, 2013 /PRNewswire-USNewswire/ -- People over 60 years old are more likely to have precancerous or cancerous polyps develop in a part of the colon that goes unseen by flexible sigmoidoscopy, a common screening test for colon and rectal cancer, a new study finds. Study results suggest the need for reviewing and possibly revising national colon...

2013-10-01 16:26:15

MADISON, N.J. and SYDNEY, Oct. 1, 2013 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that on September 30, 2013 it completed the sale of its Enterix colorectal cancer screening test business to Clinical Genomics Technologies Pty Ltd., an Australian life sciences company. Terms of the transaction were not disclosed. (Logo: http://photos.prnewswire.com/prnh/20130717/NY48934LOGO ) At its Investor Day...

2013-10-01 12:30:18

Results of recent survey confirm the advantages of invendo's single-use colonoscope NEW YORK and KISSING, Germany, Oct. 1, 2013 /PRNewswire/ -- invendo medical, manufacturer and distributor of a single-use and computer-assisted ("robotic") colonoscopy system, today announced the results of a survey examining key barriers that impact colorectal cancer screening compliance. Screening has been shown to decrease colorectal cancer rates in the United States, but according to the American Cancer...

2013-10-01 10:11:25

Younger patients with colorectal cancer that has spread to other parts of the body represent a high-risk group that is less likely to respond to treatment. Colorectal cancer in patients younger than 40 is more likely to grow despite treatment and young patients are at greater risk of death than people in other age groups. That’s according to research presented to the 2013 European Cancer Congress in Amsterdam. The team of scientists is led by an investigator at University of Colorado...

2013-09-30 15:46:48

Researchers believe they have discovered how aspirin improves survival in patients diagnosed with colon cancer, the 2013 European Cancer Congress (ECC2013) heard today (Monday). Although previous research has shown that taking low dose aspirin after being diagnosed with colon cancer improves patient outcome, the reasons why this happens remain unknown. The new research has shown that aspirin improves outcome in patients whose tumor cells express a specific protein on their surface; the...

2013-09-28 08:20:17

AMSTERDAM, Sept. 28, 2013 /PRNewswire/ -- The Angiogenesis Foundation released a white paper at the 2013 European Cancer Congress that addresses the needs, challenges, and proposed solutions for improving treatment of metastatic colorectal cancer (mCRC), the third most common cancer among men and the second most common among women worldwide. The white paper, "Improving Outcomes in the Treatment and Management of Metastatic Colorectal Cancer," is the result of the International Expert...

Colorectal Cancer Screening Effective At Reducing Mortality Rates
2013-09-28 04:55:59

redOrbit Staff & Wire Reports - Your Universe Online “Irrefutable” evidence that colorectal cancer (CRC) screening is effective at reducing the disease’s mortality rate should lead healthcare policymakers to shift resources currently devoted to breast and prostate cancer screenings to CRC testing, Belgian epidemiologist Philippe Autier will report this weekend. Autier, the vice president of population studies at the International Prevention Research Institute in France, will...

2013-09-28 04:20:17

Trial Evaluated Nearly 1,000 Patients With Metastatic Colorectal Cancer THOUSAND OAKS, Calif., Sept. 28, 2013 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced detailed results from the Phase 3 ASPECCT ('763) trial comparing Vectibix(®) (panitumumab) to Erbitux(®) (cetuximab) for the treatment of wild-type KRAS metastatic colorectal cancer in patients who have not responded to chemotherapy. The study met its primary endpoint, demonstrating that panitumumab was non-inferior to cetuximab...

2013-09-27 10:14:29

The 'HARM score' -- calculated from length-of-stay, readmission rate, and mortality Since the publication in 2000 of a report titled "To Err is Human" by the Institute of Medicine which called for a reduction in preventable medical errors, there has been an increasing demand for making improvements in the quality and measurement of health care outcomes. Although many measures have been developed, they tend to be complex, labor intensive, have an unclear relationship with improved outcomes,...

2013-09-25 12:28:16

Increased Incidence and the Launches of Premium-Priced Agents Will Sustain Four Percent Annual Growth in the Turkish Market, According to a New Report from Decision Resources BURLINGTON, Mass., Sept. 25, 2013 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, forecasts that, from 2012 to 2017, the colorectal cancer (CRC) market in Turkey will grow at an annual rate of four percent, reaching $90 million...


Latest Colorectal cancer Reference Libraries

Sigmoidoscopy
2013-03-04 10:30:47

Sigmoidoscopy is a medical procedure in which the physician is able to visualize the inside walls of the large intestine with a scope placed in the rectum. Only the distal part of the colon, or the sigmoid, is examined as opposed to the entire bowel in a colonoscopy. Reasons for procedure The use of this procedure is mainly for early detection of colorectal cancer, vascular abnormalities or polyps. Studies have shown that this procedure has aided in early detection of colorectal cancer...

More Articles (1 articles) »